Ularitide

N/A

Report date: 2023/05/19 20:00:21

Base Information

Drug NameUlaritide
Drug Alias NameUlaritide acetateAtriopeptin (95-126)Atrial natriuretic factor prohormone (95-126)Atrial natriuretic factor (95-126)CDD ANP-95-126 +[9] 
ClassificationBiologics
Mechanisms of ActionAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsAcutely decompensated congestive heart failureDeathAscites +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCardiopep PharmaUniversity Of HeidelbergCardiorentis Ag +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAarhus UniversityCardiorentis AgUniversity Of Colorado Denver +[4] 
Active IndicationsN/A
Inactive IndicationsAcutely decompensated congestive heart failureDeathAscites +[7] 

Other Information

ATC CodeN/A
Related LinksN/A